Overall Status

Recruiting (14)

Completed (7)

Not yet recruiting (4)

Withdrawn (2)

Suspended (1)

Phase

n/a (12)

phase 1 (3)

phase 2 (3)

phase 4 (2)

early phase 1 (1)

phase 1/phase 2 (1)

phase 3 (1)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Fondation Paul Bennetot (1)

London Health Sciences Centre (1)

McMaster University (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)

National Medical Research Council (NMRC), Singapore (1)

Universidade Federal do Rio Grande do Norte (1)

University Health Network, Toronto (1)

Study Documents

BECK DEPRESSION INVENTORY (1)

SF-36 QUESTIONNAIRE (1)

Intervention Type

drug (11)

other (9)

behavioral (4)

device (2)

procedure (2)

Funder Type

Other (20)

Industry (4)

NIH (4)

Study Type

Interventional (23)

Observational (5)

cognition disorder

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

fMRI and NIRS Imaging for Traumatic Brain Injury

Withdrawn

Cognition Disorder
Functional Brain Imaging

(no location specified)

Jun 30, 2017

Autism, Cognition Disorder Trial run by the NIMH (Donepezil HCl, Increase REM sleep percentage)

Completed

Has Results

Autism
Cognition Disorder

Donepezil hydrochloride
Increase REM sleep percentage

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Apr 22, 2013

Cognition Disorder, Nervous System Diseases, Mental Disorders Trial (galantamine hydrobromide)

Completed

Cognition Disorder
+3 more

galantamine hydrobromide

(no location specified)

May 17, 2011